Table 5.

Outcome and Follow-up.

Outcome at last visit
N. of patients included		401 (89.1%)
Success (n,%)		318 (79.3%)
Failure for persistent infection (n,%)		44 (11.0%)
Failure for relapse (n,%)		21 (5.2%)
Failure for need to switch therapy (n,%)		10 (2.5%)
Lost-to-follow-up (n,%)		5 (1.2%)
Infection-related death (n,%)		1 (0.2%)
Unrelated death (n,%)		2 (0.5%)
Outcome within and after 4 weeks since the end of treatment
N. of patients included		12; 274 (60.9%)
	Outcome within 4 weeks	Outcome after 4 weeks
Success (n,%)	231 (84.3%)	212 (77.4%)
Failure-persistent infection (n,%)	37 (13.5%)	25 (9.1%)
Failure-relapse (n,%)	2 (0.7%)	20 (7.3%)
Failure-switch therapy (n,%)	0 (0.0%)	10 (3.6%)
Lost-to-follow-up (n,%)	4 (1.5%)	5 (1.8%)
Infection-related death (n,%)	0 (0.0%)	0 (0.0%)
Unrelated death (n,%)	0 (0.0%)	2 (0.7%)